CD146参与Wnt5a/JNK信号通路及其对糖尿病肾病足细胞损伤和上皮间充质转变现象的作用机制研究
批准号:
81670657
项目类别:
面上项目
资助金额:
58.0 万元
负责人:
汪年松
依托单位:
学科分类:
继发性肾脏疾病
结题年份:
2020
批准年份:
2016
项目状态:
已结题
项目参与者:
姚正菊、范瑛、费杨、闻洁君、姜珍珍、张婧、何俐
中文摘要
“上皮间充质转变(EMT)现象”是糖尿病肾病(DN)足细胞损伤的核心环节,Wnt非经典通路“Wnt5a/JNK”在肾脏疾病时激活,与足细胞损伤相关。研究发现跨膜受体蛋白CD146介导Wnt5a/JNK通路,在维持细胞形态、促进细胞分化等方面发挥重要作用。在我们前期研究中,证实了DN患者血清和肾组织中CD146表达增强且与疾病进程相关;验证了CD146在肾小管细胞和足细胞表达,参与Wnt5a/JNK通路,与足细胞间充质表型获得有关;发现了Wnt5a基因敲除小鼠能通过抑制肾脏CD146表达改善单侧输尿管结扎侧的肾小管间质损伤和“EMT现象”。本项目将基于既往的工作基础,通过构建Wnt5a基因敲除小鼠单侧肾切除联合STZ诱导的DN模型,结合体外实验和DN患者肾脏组织学研究,多层次探讨CD146介导Wnt5a/JNK通路在足细胞损伤和“EMT现象”中的机制,为DN的发病机制研究开拓新的思路。
英文摘要
Podocytes are specialized, terminally differentiated visceral epithelial cells that cover the outer aspect of the glomerular basement membrane (GBM), playing a crucial role in the regulation of glomerular function. Podocytes undergo Epithelial-Mesenchymal Transition (EMT) after injury, which is considered a key event in the progression of diabetic nephropathy (DN). Recent years, EMT is more properly termed as “EMT-like change”, defining as the acquisition of mesenchymal properties by epithelial cells and the activation of related intracellular signaling pathways, rather than a full-way epithelial-to-fibroblast transition. Wnt5a/JNK is one of the major non-canonical Wnt pathways activated in DN. Wnt5a signaling plays an important role in podocyte depletion and dedifferentiation. A recent striking study identified CD146 as a transmembrane receptor of Wnt5a in regulating cell differentiation and migration. CD146 is a novel recognized gene related with kidney diseases, yet its underlying mechanism in kidney diseases remains poorly understood. In our previous studies, we identified the expression of CD146 in podocytes and renal tubular epithelial cells. We demonstrated a significant increase of CD146 expression in both serum and kidney biopsy tissues in patients with DN. We also verified the role of CD146 in Wnt5a/JNK pathway in vitro and found a possible role of CD146 in “EMT-like change” of podocytes. Furthermore, we found that Wnt5a knockout mice were protected from the development of renal fibrosis and “EMT-like change” in the unilateral ureteral obstruction (UUO) model via suppression of CD146/Wnt5a/JNK signaling. . Therefore, in the present study, we like to make further functional study of CD146 in DN. We plan to investigate the role of CD146 in podocyte injury and “EMT-like change” under high glucose or albumin over-loading conditions in vitro; we will explore the relationship between CD146 and podoctye injury in human kidney biopsies of DN by conducting a pathological study on CD146 and podoctye markers in vivo; Also, we will study CD146 mediated Wnt5a/JNK signaling in Wnt5a conventional knockout mice. Since STZ induced type 1-diabetes mice with uninephrictomy present more pronounced kidney and podocyte injury, therefore, we try to investigate whether suppression of CD146/Wnt5a attenuates podoctye injury and “EMT-like change” in the kidneys of STZ induced diabetic nephropathy with uninephrectomy. Thus targeting CD146/Wnt5a signaling could be an attractive strategy for therapeutic intervention of diabetic kidney disease.
Wnt非经典通路“Wnt5a/JNK”在肾脏疾病时激活,与肾脏损伤相关。研究发现跨膜受体蛋白CD146介导Wnt5a/JNK通路,在维持细胞形态、促细胞分化等方面发挥重要作用。在我们前期研究中,证实了DN患者血清和肾组织中CD146表达增强且与疾病进程相关;验证了CD146在小管细胞和足细胞表达,参与Wnt5a/JNK通路;发现了Wnt5a基因敲除小鼠能通过抑制肾脏CD146表达改善单侧输尿管结扎侧的肾损伤和“EMT现象”。本项目基于既往工作,首次深入CD146与DN发病机制研究,构建Wnt5a基因敲除小鼠单侧肾切除联合STZ诱导的DN模型,结合体外实验和DN人肾组织学研究,多层次探讨CD146介导Wnt5a/JNK通路在足细胞损伤和“EMT现象”中的机制,为DN多靶点治疗提供新方向。具体开展的研究内容如下:.(1)进行了Wnt5a/CD146信号通路调控糖尿病肾病肾小管间质炎症的作用及机制研究。.(2)探讨了Wnt5a/CD146信号通路调控急性肾损伤肾小管上皮细胞损伤和上皮间充质转变现象的作用机制。.(3)探究糖尿病sCD146水平与肾脏损伤进展、动脉粥样硬化及心血管事件的相关性,探寻糖尿病肾病潜在生物标志物。
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
登录
查看更多内容
DOI:
--
发表时间:
2019
期刊:
中国血液净化
影响因子:
--
作者:
[乔诚, 程东生, 吴险峰, 赵晋媛, 汪年松, 许涛]
通讯作者:
许涛
DOI:
10.1007/s11892-017-0842-y
发表时间:
2017
期刊:
Current Diabetes Reports
影响因子:
4.2
作者:
[Fan Ying, Lee Kyung, Wang Niansong, He John Cijiang]
通讯作者:
He John Cijiang
DOI:
--
发表时间:
2019
期刊:
中国中西医结合肾病杂志
影响因子:
--
作者:
[乔诚, 赵黎, 张海静, 倪燕萍, 许涛, 汪年松]
通讯作者:
汪年松
Sitagliptin ameliorates renal tubular injury in diabetic kidney disease via STAT3-dependent mitochondrial homeostasis through SDF-1α/CXCR4 pathway.
西他列汀通过 SDF-1α/CXCR4 途径通过 STAT3 依赖性线粒体稳态改善糖尿病肾病的肾小管损伤。
DOI:
10.1096/fj.201903038r
发表时间:
2020
期刊:
The FASEB J
影响因子:
--
作者:
[Zhang Qunzi, He Li, Dong Yang, Fei Yang, Wen Jiejun, Li Xiaomei, Guan Jian, Liu Feng, Zhou Ting, Li Ze, Fan Ying, Wang Niansong]
通讯作者:
Wang Niansong
Inhibition of Reticulon-1A-Mediated Endoplasmic Reticulum Stress in Early AKI Attenuates Renal Fibrosis Development
抑制早期 AKI 中 Reticulon-1A 介导的内质网应激可减轻肾纤维化发展
DOI:
10.1681/asn.2016091001
发表时间:
2017-07-01
期刊:
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
影响因子:
13.6
作者:
[Fan, Ying, Xiao, Wenzhen, He, John Cijiang]
通讯作者:
He, John Cijiang
共 18 条
Wnt5a-FOXP1-Notch2调控轴介导糖尿病肾病肾小管损伤的机制研究
-
批准号:82270761
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:汪年松
-
依托单位:
Renalase 通过调控PMCA4b/calcineurin/NFAT信号通路抑制慢性肾脏病心肌重构的分子机制研究
-
批准号:81870504
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:汪年松
-
依托单位:
renalase对慢性肾脏疾病患者心血管事件的预测价值及renalase替代治疗慢肾衰的实验研究
-
批准号:81270824
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2012
-
负责人:汪年松
-
依托单位:
国内基金
海外基金